Results 81 to 90 of about 12,682 (143)

Current perspectives on lipid management in diabetic kidney disease: Can fibrates offer advantages over statins for renal outcomes? [PDF]

J Res Med Sci
Chitsazi MR, Safari F, Malekpour E, Mirzaei SA, Shafieyoun MH, Golafshan F, Rouzbahani H, Nekookhoo M, Noursina A, Siavash M.   +9 more
europepmc   +1 more source

2025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk? [PDF]

Arch Med Sci
Toth PP, Banach M, International Lipid Expert Panel (ILEP).   +2 more
europepmc   +1 more source

Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Kim JY, Kim NH, Lee J, Kim DH, Kim SG.
europepmc   +1 more source

Fenofibrate differentially activates PPARα-mediated lipid metabolism in rat kidney and liver. [PDF]

Sci Rep
Pannala VR, Balik-Meisner MR, Mav D, Phadke DP, Scholl EH, Shah RR, Casey W, Auerbach SS, Wallqvist A.   +8 more
europepmc   +1 more source

Alternate-day alternating monotherapy (q48h) versus daily concomitant atorvastatin-fenofibrate in adults with type 2 diabetes and mixed dyslipidemia: a 12-week randomized non-inferiority trial. [PDF]

BMC Endocr Disord
Shahramirad S, Rezvani M, Jahanbazi R, Vataniman M, Razavianzadeh N.   +4 more
europepmc   +1 more source

Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model. [PDF]

Oncogene
Guo W, Wang X, Cui G, Schmieder EAS, Gao Y, Zhang B, Martin RCG, Bai O, Li Y.   +8 more
europepmc   +1 more source

PPARα modulation of macrophage polarization and inflammatory signaling in mimic periodontitis. [PDF]

J Appl Oral Sci
Arthur HU, Chen YY.
europepmc   +1 more source

Looking Beyond Severe Hypertriglyceridemia when Diagnosing Adult-Onset Citrullinemia Type II. [PDF]

Eur J Case Rep Intern Med
Truong TH, Kim NT, Do DL, Vu MP, Nguyen MT, Le HA, Le TT.   +6 more
europepmc   +1 more source

Are lipid-lowering therapies used according to the guidelines?: A real-world retrospective study of 1001 patients with type 2 diabetes. [PDF]

Medicine (Baltimore)
Şahin MF, Erol A, Bayrak G, Şahin A.
europepmc   +1 more source

Peroxisome proliferator‑activated receptor α regulates acesulfame‑K‑induced NAFLD via hepatic PLCβ: Foe and friend. [PDF]

Int J Mol Med
Lin PY, Xie JR, Qian TC, Wang SS, Yu SY, Shi WB, Wang Y, Cen LZ, Zhu QJ, Zheng YY, Gao H, Fang R, Xia ZX, Liu AM, Xu L.   +14 more
europepmc   +1 more source